ERBB2 and neoplasm: Endocrine therapy is prescribed for most women with oestrogen receptor positive disease, and chemotherapy is advised if poor prognostic features are present, such as large tumour size, positive lymph nodes, or high tumour grade, and for women with triple negative or human epidermal growth factor receptor 2 positive disease.